Accurate assessment of kidney size in paediatric populations is crucial for distinguishing normal organ growth from pathological alterations associated with congenital or acquired renal conditions.

Because treatment with growth hormone (GH), often necessitated by GH deficiency from childhood cancer, has been linked to tumorigenesis, concerns remain around its use among childhood cancer survivors ...

Please provide your email address to receive an email when new articles are posted on . At baseline, 26.6% of children with Crohn’s had a weight disturbance, 27.7% had a height disturbance and 19.7% ...

Recent research identified spinal muscular atrophy (SMA)–specific growth percentiles, aiming to improve clinical management of the nutritional aspects of the disease. Due to the nature of SMA, the ...

Children who received recombinant human growth hormones (rhGHs) were at an increased risk of cardiovascular events once they reached early adulthood in a Swedish cohort study. Among 3,408 patients on ...

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla), a ...

Children's Hospital of Philadelphia's Center for Data Driven Discovery in Biomedicine finds AI in Pediatric Neuro-Oncology Surpasses Manual Measures PHILADELPHIA, Oct. 28, 2025 /PRNewswire/ -- ...

Neuroblastoma remains one of the deadliest childhood malignancies, accounting for a disproportionate number of pediatric cancer deaths worldwide. Despite major therapeutic advances, survival rates ...